A rapid, accurate method for determining diphenylhydantoinand phenobarbital in a single biologic sample is described. Separation of the two drugs after their initial chloroform extraction from the specimen is not required. After extraction, diphenylhydantoin is converted to benzophenone by pemanganate oxidation. Phenobarbital is determined by differential absorption between pH values of 12.0 and 10.5. Final quantitation in each case is carried out by ultraviolet spectrophotometry. Barbiturates do not interfere with the diphenyihydantoin analysis or vice versa. The method is sensitive enough for detecting subtherapeutic amounts of each compound with a high degree of specificity.
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HE ABILITY
to rapidly determine therapeutic concentrations of diphenylhydantoin and phenobarbital when concomitantly present in small amounts of biologic specimens has long been needed in laboratory medicine.
A requirement exists for concentrations of the drugs in blood during the treatment of numerous types of neurologic disorders. Determination of the two drugs has been described in several reports
(1-3). 
Gas chiromatographic methods

Procedure
The volumes of 5-8 nil of whole 1)100(1, serum, plasma, or urine are adjusted to a pH between 6.0 and 7.5 by the dropwise addition of either 0.5 N HCl or 0.45 N NaOH, and placed in a 250-mi separatory funnel to which is added 100 ml of chloroform.
This Care should be taken to recover as much of the alkaline layer as possible.
in each of two microcuvets (Scientific Glass Apparatus Co., Inc., No. S-4821-2, Type IS or equivalent) of 1.0-mi capacity is placed 0.6 ml of the aqueous layer. To one cuvet is added 0.1 ml of 0.45 N NaOH, and to the other, 0.1 ml of 16% NH4C1. The difference in abs#{243}rbancebetween the two solutions at 260 m is used to calculate the phenobarbital concentration (10).
Of the remaining aqueous alkaline extract, 3 ml is placed in a 250-mi round-bottom flask, which is then connected to a vacuum rotary assembly. With vacuum applied, the flask is rotated in a water bath at 50-60#{176} until the volume is reduced to less than 1 ml; this is done to remove traces of chloroform.
With a good vacuum this operation should require only S mm. The flask is removed from the assembly, and 20 ml of KMnO4 reagent and 5 ml of spectro-quality n-heptane are added. The extent to which diphenylhydaiitoin interferes with phenobarbital, when the latter is determined by difference in the absorption at 26() flij.t, has not been reported in the scientific literature.
To establish this relationship, two matched cuvets containing dpihenylhydantoin solutions of equivalent concentration were adjusted to pH 12.0 and 10.5 and used as sample and reference cells, respectively, it was observed that concentrations of diphenylhydantoin up to 100 jLg/ml afford less than 0.01 differential absorbance at 260 m. Figure  2 demonstrates the lack of interference by diphenylhydantoin in the analysis of phellobarbital and vice versa. In fact, high levels of diphenylhydantoin do not affect the determination of phenobarbital (Fig. 3) tion curve of the diphenylhydantoin product (Fig. 4) . The reproducibility of results was excellent (Table  2) . With each drug, recoveries from whole blood were better than 90%.
The sensitivity of the method is such that as little as 4- 
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